KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics (PVLA) Change in Receivables (2016 - 2017)

Historic Change in Receivables for Palvella Therapeutics (PVLA) over the last 3 years, with Q4 2017 value amounting to $12.1 million.

  • Palvella Therapeutics' Change in Receivables changed N/A to $12.1 million in Q4 2017 from the same period last year, while for Sep 2024 it was $12.1 million, marking a year-over-year change of. This contributed to the annual value of -$5.3 million for FY2023, which is 30224.85% down from last year.
  • As of Q4 2017, Palvella Therapeutics' Change in Receivables stood at $12.1 million.
  • Palvella Therapeutics' Change in Receivables' 5-year high stood at $46.5 million during Q2 2017, with a 5-year trough of -$44.1 million in Q3 2017.
  • In the last 3 years, Palvella Therapeutics' Change in Receivables had a median value of -$43940.5 in 2014 and averaged $1.7 million.
  • Examining YoY changes over the last 5 years, Palvella Therapeutics' Change in Receivables showed a top increase of 12806.45% in 2017 and a maximum decrease of 12806.45% in 2017.
  • Palvella Therapeutics' Change in Receivables (Quarter) stood at -$474418.0 in 2014, then soared by 114.52% to $68870.0 in 2016, then skyrocketed by 17515.96% to $12.1 million in 2017.
  • Its Change in Receivables stands at $12.1 million for Q4 2017, versus -$44.1 million for Q3 2017 and $46.5 million for Q2 2017.